What is the latest ARVEE stock price?
The latest stored price for ARVEE is Rs 155.36 as of 2026-07-21.
gimli
ARVEE stock AI analysis
ARVEE Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
ARVEE LABORATORIES I LTD is a small-cap stock in Chemicals. This Gimli page shows the latest available ARVEE price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹155.36
1W return
-2.29%
1M return
-6.96%
3M return
-8.51%
6M return
+1.78%
1Y return
-11.28%
Market cap
₹171.21 cr
PE
82.31
PB
5.45
ROE
+6.89%
ROCE
+5.77%
RSI
37.42
Turnover
₹0.02 cr
Why it can matter in screens
- Momentum: ARVEE is below 50DMA, below 200DMA; RSI is 37.42.
- Returns: 1D -1.67%, 1W -2.29%, 1M -6.96%, 3M -8.51%, 1Y -11.28%.
- Trend levels: 52W high ₹290.78, 52W low ₹133.86, off high -46.57%.
- Liquidity: latest turnover is ₹0.02 cr; volume vs 20D is +0.91%.
- Valuation/profitability: PE 82.31, PB 5.45, ROE +6.89%, ROCE +5.77%.
- Growth: 3Y sales CAGR -1.06%, 3Y profit CAGR -5.77%.
Quick Answers
Is ARVEE above its 50DMA and 200DMA?
ARVEE is below 50DMA, below 200DMA. The latest 50DMA is 163.10 and the latest 200DMA is 168.23.
What are ARVEE PE, ROE and ROCE?
ARVEE has PE 82.31, ROE +6.89%, and ROCE +5.77% in Gimli's latest available snapshot.
How has ARVEE performed recently?
ARVEE has returned -6.96% over 1 month, -8.51% over 3 months, and -11.28% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2025-12-31 | 9.78 cr | 1.76 cr | 1.83 cr | 1.66 |
| 2025-09-30 | 3.45 cr | 0.36 cr | 0.01 cr | 0.01 |
| 2025-06-30 | 7.48 cr | 0.51 cr | 0.17 cr | 0.15 |
| 2025-03-31 | 6.40 cr | 0.33 cr | 0.07 cr | nan |
| 2024-12-31 | 8.91 cr | 0.54 cr | 0.15 cr | 0.14 |
| 2024-09-30 | 12.53 cr | 1.66 cr | n/a | 0.89 |
| 2024-06-30 | 10.60 cr | 1.64 cr | 0.94 cr | 0.85 |
| 2024-03-31 | n/a | n/a | n/a | nan |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2025-03-31 | 38.44 cr | 4.17 cr | 2.15 cr | 1.95 |
| 2024-03-31 | 30.34 cr | 3.52 cr | 1.05 cr | 0.95 |
| 2023-03-31 | 61.28 cr | 8.53 cr | 4.12 cr | 3.74 |
| 2022-03-31 | 39.69 cr | 6.15 cr | 2.57 cr | 2.34 |
| 2021-03-31 | n/a | n/a | n/a | nan |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2025-03-31 | 37.57 cr | 0.21 cr | 1.03 cr | 31.26 cr |
| 2024-03-31 | 38.56 cr | 1.85 cr | 1.00 cr | 29.11 cr |
| 2023-03-31 | 38.69 cr | 0.54 cr | 1.00 cr | 28.06 cr |
| 2022-03-31 | 38.68 cr | 1.28 cr | 3.13 cr | 23.94 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2025-03-31 | -0.21 cr | -2.06 cr | n/a |
| 2024-03-31 | 3.66 cr | 1.08 cr | n/a |
| 2023-03-31 | 2.93 cr | 1.44 cr | n/a |
| 2022-03-31 | 0.68 cr | -1.68 cr | n/a |
| 2021-03-31 | n/a | n/a | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-03-31 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | +0.00% |
| 2025-12-31 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | +0.00% |
| 2025-09-30 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | +0.00% |
| 2025-06-30 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | +0.00% |
| 2025-03-31 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | +0.00% |
| 2024-12-31 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | +0.00% |
| 2024-09-30 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | +0.00% |
| 2024-06-30 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | +0.00% |
| 2024-03-31 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | +0.00% |
| 2023-12-31 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | +0.00% |
| 2023-09-30 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | +0.00% |
| 2023-06-30 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | +0.00% |
| 2023-03-31 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | n/a |
| 2022-12-31 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | +0.00% |
| 2022-09-30 | +73.50% | +0.00% | +0.00% | +0.00% | +26.50% | n/a |
| 2022-06-30 | +73.50% | +0.00% | +0.00% | n/a | n/a | n/a |
| 2022-03-31 | +73.50% | +0.00% | +0.00% | n/a | n/a | +0.00% |
| 2021-12-31 | +73.50% | +0.00% | +0.00% | n/a | n/a | +0.00% |
| 2021-09-30 | +73.50% | +0.00% | +0.00% | n/a | n/a | +0.00% |
| 2021-06-30 | +73.50% | +0.00% | +0.00% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SOLARINDS | SOLAR INDUSTRIES (I) LTD | 172,338.40 cr | 102.732196 | +30.27% | +27.60% |
| PIDILITIND | PIDILITE INDUSTRIES LTD | 161,958.58 cr | 65.989994 | +23.37% | +7.34% |
| SRF | SRF LTD | 87,113.72 cr | 47.468762 | +13.76% | -6.11% |
| COROMANDEL | COROMANDEL INTERNTL. LTD | 60,543.98 cr | 31.139858 | +15.97% | -12.18% |
| LINDEINDIA | LINDE INDIA LIMITED | 59,733.05 cr | 108.811304 | +13.58% | +4.71% |
| FACT | FACT LTD | 53,926.98 cr | -1361.792436 | -2.91% | -13.20% |
| UPL | UPL LIMITED | 52,182.33 cr | 26.341406 | +5.01% | -13.39% |
| FLUOROCHEM | GUJARAT FLUOROCHEM LTD | 50,608.99 cr | 87.558812 | +7.60% | +28.93% |
Try these prompts
- Analyze ARVEE LABORATORIES I with valuation, momentum and industry peers
- Compare ARVEE with other Chemicals stocks
- Show small-cap stocks in Chemicals above 50DMA with positive 1M return
- Find Chemicals stocks with improving momentum and reasonable valuation
Related screen ideas
- View Chemicals stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare ARVEE with other Chemicals stocks
Data snapshot: 2026-07-21. Not investment advice.